Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s resubmission of its BLA for Awiqli, the FDA’s approval of Kedrion’s Qivigy for pri…
7 months, 2 weeks ago
Pharmaceutical Executive Daily: September 30, 2025
In today’s Pharmaceutical Executive Daily, we cover AbbVie’s new API manufacturing site in Illinois, AstraZeneca’s plan to harmonize its global stock…
7 months, 3 weeks ago
Pharmaceutical Executive Daily: September 29, 2025
In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels as…
7 months, 3 weeks ago
Pharmaceutical Executive Daily: September 26, 2025
In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of Eli Li…
7 months, 3 weeks ago
Pharmaceutical Executive Daily: September 25, 2025
In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial setba…
7 months, 3 weeks ago
Pharmaceutical Executive Daily: September 24, 2025
In today’s Pharmaceutical Executive Daily, we cover the market reaction to Trump’s Tylenol–autism claim, the FDA’s complete response letter to Schola…
7 months, 3 weeks ago
Pharmaceutical Executive Daily: September 23, 2025
In today’s Pharmaceutical Executive Daily, we cover GSK’s supplemental application to update the label for Leucovorin, the FDA’s complete response le…
7 months, 4 weeks ago
Pharmaceutical Executive Daily: September 22, 2025
In today’s Pharmaceutical Executive Daily, we cover Biogen’s acquisition of Alcyone Therapeutics to expand its drug delivery solutions, the FDA’s exp…
7 months, 4 weeks ago
Pharmaceutical Executive Daily: September 19, 2025
In today’s Pharmaceutical Executive Daily, we cover how pharma companies can scale AI pilots into enterprise-wide value, GSK’s plan to invest $30 bil…
8 months ago
Pharmaceutical Executive Daily: September 18, 2025
In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock Bio’s $50 million Series A f…
8 months ago